# Bill Greenhalf

Source: https://onco.cc/people/bill-greenhalf/  
OnCo record `bill-greenhalf` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Liverpool molecular scientist behind the EUROPAC registry's laboratory work and the biomarker analyses of the ESPAC trial samples.

## Summary

Bill Greenhalf is a Reader in Molecular and Clinical Cancer Medicine at the University of Liverpool (Institute of Systems, Molecular and Integrative Biology). He works on the molecular side of the EUROPAC registry of familial pancreatic cancer and hereditary pancreatitis and on biomarker studies from the ESPAC trials, including the ESPAC-3 analysis of tumour hENT1 expression and survival from gemcitabine (Journal of the National Cancer Institute 2014) and the Liverpool Experimental Cancer Medicine Centre biomarker discovery programme (ISRCTN74588872).

## Fields

- Kind: Person
- Last checked: 2026-09-24
- Tags: pancreatic; uk; biomarkers
- Role: Reader, Molecular and Clinical Cancer Medicine, University of Liverpool
- Specialisms: Familial pancreatic cancer; Hereditary pancreatitis; Biomarkers; Molecular pathology of ESPAC samples

## Sources

- University of Liverpool staff page: https://www.liverpool.ac.uk/people/william-greenhalf

## Connected records

- people: [Chris Halloran](https://onco.cc/people/chris-halloran/)
- cancers: [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- institutions: [Liverpool University Hospitals HPB centre (Aintree)](https://onco.cc/institutions/liverpool-hpb-centre/)
- trials: [ESPAC-3](https://onco.cc/trials/espac-3/), [EUROPAC](https://onco.cc/trials/europac/)

---
JSON: https://onco.cc/api/v1/entities/bill-greenhalf.json